IN8bio Inc.

NASDAQ: INAB · Real-Time Price · USD
2.35
-0.05 (-2.08%)
At close: Aug 15, 2025, 3:59 PM
2.29
-2.55%
After-hours: Aug 15, 2025, 06:39 PM EDT

IN8bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-30.44M -30.01M -28.52M -14.65M
Depreciation & Amortization
2.65M 2.5M 1.1M 788K
Stock-Based Compensation
5M 4.37M 3.47M 2.19M
Other Working Capital
-877K 777K -1.68M -1.52M
Other Non-Cash Items
45K n/a 4.16M 541K
Deferred Income Tax
n/a n/a -4.16M -541K
Change in Working Capital
-1.41M -204K -170K -1.84M
Operating Cash Flow
-24.15M -23.34M -24.12M -13.51M
Capital Expenditures
-104K -600K -3.71M -309K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-83K n/a n/a n/a
Investing Cash Flow
-187K -600K -3.71M -309K
Debt Repayment
-794K -798K -615K -709K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.04M 3.28M 61K -2.66M
Financial Cash Flow
14.18M 27.04M 8.99M 32.95M
Net Cash Flow
-10.15M 3.1M -18.84M 19.14M
Free Cash Flow
-24.25M -23.94M -27.83M -13.82M